CD38 and Miyoshi myopathy: Given in vitro data showing CD38 deletion protected NK cells from DARA-induced fratricide, we hypothesized that both NK cell persistence and cytotoxicity against MM target cells would be augmented in tumor-bearing mice receiving treatment with CD38KO NK cells and DARA.